(Q44924772)

7 December 2017

title

Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir (English)

1 reference

7 December 2017

main subject

anti-retroviral agent

0 references

1 reference

1 reference

1 reference

1 reference

Elinore F McCance-Katz

1

1 reference

7 December 2017

David E Moody

2

1 reference

7 December 2017

Patrick F Smith

3

1 reference

7 December 2017

Gene D Morse

4

1 reference

7 December 2017

Gerald Friedland

5

1 reference

7 December 2017

Patricia Pade

6

1 reference

7 December 2017

Jennifer Baker

7

1 reference

7 December 2017

Anika Alvanzo

8

1 reference

7 December 2017

Peter Jatlow

9

1 reference

7 December 2017

Petrie M Rainey

10

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 December 2006

1 reference

Clinical Infectious Diseases

7 December 2017

published in

1 reference

7 December 2017

volume

43 Suppl 4

1 reference

7 December 2017

page(s)

S235-46

1 reference

Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users

7 December 2017

cites work

1 reference

Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

21 January 2018

1 reference

Barriers to use of free antiretroviral therapy in injection drug users.

21 January 2018

1 reference

Medical care for injection-drug users with human immunodeficiency virus infection

21 January 2018

1 reference

The impact of HIV infection on medical services in drug abuse treatment programs

21 January 2018

1 reference

HIV-1 infection in injection drug users

21 January 2018

1 reference

Treatment for drug dependence

21 January 2018

1 reference

Hepatitis C: an update on the silent epidemic

21 January 2018

1 reference

Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents

21 January 2018

1 reference

Drug interactions between opioids and antiretroviral medications: interaction between methadone, LAAM, and nelfinavir

21 January 2018

1 reference

The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients

21 January 2018

1 reference

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

21 January 2018

1 reference

Office-based buprenorphine treatment for opioid-dependent patients

21 January 2018

1 reference

21 January 2018

1 reference

Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma

21 January 2018

1 reference

Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine

21 January 2018

1 reference

Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone

21 January 2018

1 reference

Nelfinavir: an update on its use in HIV infection

21 January 2018

1 reference

Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives

21 January 2018

1 reference

Modified Directly Observed Therapy (MDOT) for Injection Drug Users with HIV Disease

21 January 2018

1 reference

Two New Rating Scales for Opiate Withdrawal

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/508188

1 reference

7 December 2017

1 reference